312 related articles for article (PubMed ID: 29957668)
21. The Potential of MicroRNAs as Novel Biomarkers for Transplant Rejection.
Hamdorf M; Kawakita S; Everly M
J Immunol Res; 2017; 2017():4072364. PubMed ID: 28191475
[TBL] [Abstract][Full Text] [Related]
22. Immune monitoring and biomarkers to predict chronic allograft dysfunction.
Mannon RB
Kidney Int Suppl; 2010 Dec; (119):S59-65. PubMed ID: 21116320
[TBL] [Abstract][Full Text] [Related]
23. Urinary Extracellular Vesicles Are a Novel Tool to Monitor Allograft Function in Kidney Transplantation: A Systematic Review.
Wu L; Boer K; Woud WW; Udomkarnjananun S; Hesselink DA; Baan CC
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638835
[TBL] [Abstract][Full Text] [Related]
24. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study.
Schütz E; Fischer A; Beck J; Harden M; Koch M; Wuensch T; Stockmann M; Nashan B; Kollmar O; Matthaei J; Kanzow P; Walson PD; Brockmöller J; Oellerich M
PLoS Med; 2017 Apr; 14(4):e1002286. PubMed ID: 28441386
[TBL] [Abstract][Full Text] [Related]
25. Urine proteomics in kidney transplantation.
Kim SC; Page EK; Knechtle SJ
Transplant Rev (Orlando); 2014 Jan; 28(1):15-20. PubMed ID: 24321302
[TBL] [Abstract][Full Text] [Related]
26. Non-invasive molecular biomarkers for monitoring solid organ transplantation: A comprehensive overview.
Fernando JJ; Biswas R; Biswas L
Int J Immunogenet; 2024 Apr; 51(2):47-62. PubMed ID: 38200592
[TBL] [Abstract][Full Text] [Related]
27. Donor-specific circulating cell free DNA as a noninvasive biomarker of graft injury in heart transplantation.
Macher HC; García-Fernández N; Adsuar-Gómez A; Porras-López M; González-Calle A; Noval-Padillo J; Guerrero JM; Molinero P; Borrego-Domínguez JM; Herruzo-Avilés Á; Rubio A
Clin Chim Acta; 2019 Aug; 495():590-597. PubMed ID: 31175849
[TBL] [Abstract][Full Text] [Related]
28. Cell-free DNA beyond a biomarker for rejection: Biological trigger of tissue injury and potential therapeutics.
Tsuji N; Agbor-Enoh S
J Heart Lung Transplant; 2021 Jun; 40(6):405-413. PubMed ID: 33926787
[TBL] [Abstract][Full Text] [Related]
29. Sensing Acute Cellular Rejection in Liver Transplant Patients Using Liver-Derived Extracellular Particles: A Prospective, Observational Study.
Kamali K; Schmelzle M; Kamali C; Brunnbauer P; Splith K; Leder A; Berndt N; Hillebrandt KH; Raschzok N; Feldbrügge L; Felsenstein M; Gaßner J; Ritschl P; Lurje G; Schöning W; Benzing C; Pratschke J; Krenzien F
Front Immunol; 2021; 12():647900. PubMed ID: 34025656
[TBL] [Abstract][Full Text] [Related]
30. Urinary tubular biomarkers as potential early predictors of renal allograft rejection.
Ting YT; Coates PT; Walker RJ; McLellan AD
Nephrology (Carlton); 2012 Jan; 17(1):11-6. PubMed ID: 22050577
[TBL] [Abstract][Full Text] [Related]
31. Understanding Donor-derived Cell-free DNA in Kidney Transplantation: An Overview and Case-based Guide for Clinicians.
Graver AS; Lee D; Power DA; Whitlam JB
Transplantation; 2023 Aug; 107(8):1675-1686. PubMed ID: 36579675
[TBL] [Abstract][Full Text] [Related]
32. Mining the human urine proteome for monitoring renal transplant injury.
Sigdel TK; Gao Y; He J; Wang A; Nicora CD; Fillmore TL; Shi T; Webb-Robertson BJ; Smith RD; Qian WJ; Salvatierra O; Camp DG; Sarwal MM
Kidney Int; 2016 Jun; 89(6):1244-52. PubMed ID: 27165815
[TBL] [Abstract][Full Text] [Related]
33. Serum and urinary biomarkers in acute kidney transplant rejection.
Alachkar N
Nephrol Ther; 2012 Feb; 8(1):13-9. PubMed ID: 22018843
[TBL] [Abstract][Full Text] [Related]
34. Characteristics, properties, and potential applications of circulating cell-free dna in clinical diagnostics: a focus on transplantation.
Sherwood K; Weimer ET
J Immunol Methods; 2018 Dec; 463():27-38. PubMed ID: 30267663
[TBL] [Abstract][Full Text] [Related]
35. The role of donor-derived cell-free DNA in the detection of renal allograft injury.
Zhou Y; Cheng D; Jiang T
Nephrol Ther; 2021 Feb; 17(1):12-17. PubMed ID: 33454228
[TBL] [Abstract][Full Text] [Related]
36. Myriad Applications of Circulating Cell-Free DNA in Precision Organ Transplant Monitoring.
Burnham P; Khush K; De Vlaminck I
Ann Am Thorac Soc; 2017 Sep; 14(Supplement_3):S237-S241. PubMed ID: 28945480
[TBL] [Abstract][Full Text] [Related]
37. Cell-free DNA donor fraction analysis in pediatric and adult heart transplant patients by multiplexed allele-specific quantitative PCR: Validation of a rapid and highly sensitive clinical test for stratification of rejection probability.
North PE; Ziegler E; Mahnke DK; Stamm KD; Thomm A; Daft P; Goetsch M; Liang HL; Baker MA; Vepraskas A; Rosenau C; Dasgupta M; Simpson P; Mitchell ME; Tomita-Mitchell A
PLoS One; 2020; 15(1):e0227385. PubMed ID: 31929557
[TBL] [Abstract][Full Text] [Related]
38. A fast and simple method for detecting and quantifying donor-derived cell-free DNA in sera of solid organ transplant recipients as a biomarker for graft function.
Adamek M; Opelz G; Klein K; Morath C; Tran TH
Clin Chem Lab Med; 2016 Jul; 54(7):1147-55. PubMed ID: 26574891
[TBL] [Abstract][Full Text] [Related]
39. N-terminal pro-brain natriuretic peptide as a potential non-invasive marker of cardiac transplantation rejection.
Avello N; Molina BD; Llorente E; Bernardo MJ; Prieto B; Alvarez FV
Ann Clin Biochem; 2007 Mar; 44(Pt 2):182-8. PubMed ID: 17362585
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive diagnosis of acute rejection of solid organ transplants.
Hartono C; Dadhania D; Suthanthiran M
Front Biosci; 2004 Jan; 9():145-53. PubMed ID: 14766354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
